Latest Working Capital News

SPC Global Holdings confirms FY2025 pro forma EBITDA guidance of A$29 million, driven by strong early post-merger performance and strategic initiatives including site consolidation and leadership renewal.

Mighty Kingdom Limited has completed its entitlement offer, raising approximately A$475,000 through the issuance of 95 million new shares, yet a significant shortfall remains to be placed with investors.

Brightstar Resources has locked in a US$11.5 million revolving finance facility with Ocean Partners, bolstering working capital to fuel production expansion and exploration across its Western Australian gold projects in 2025.

Enlitic Inc. has been reinstated to trading on the ASX following its announcement of a new equity raise, signaling renewed investor interest in the health technology firm.

Enlitic has signed a binding MoU with GE HealthCare to deliver up to A$50 million in migration services over five years, contingent on a A$10 million equity raise that the company has now initiated.

Proteomics International Laboratories Ltd is raising up to $5.5 million through a $4 million placement and a $1 million Share Purchase Plan at $0.37 per share, offering shareholders a discounted entry and free attaching options.

Excite Technology Services has raised $2.8 million through a placement to accelerate growth in cybersecurity services and training, including investment in its flagship Nangu Tactical Centre.

DTI Group Limited has announced a fully underwritten pro-rata entitlement offer to raise approximately $2.69 million, primarily aimed at repaying a $1.25 million loan from major shareholder Finico Pty Ltd. The offer opens on 13 May and closes on 10 June 2025, with new shares priced at $0.006 each.

Enlitic has formalised a binding MOU with GE HealthCare to deliver multi-million-dollar migration services, contingent on raising A$10 million through a new capital placement. This partnership and funding round mark a pivotal step in Enlitic’s growth strategy within AI-driven medical imaging.

AdAlta Limited has announced a pro rata renounceable rights offer to raise approximately $1.29 million, aiming to fund its strategic pivot towards licensing CAR-T cell therapies through its subsidiary AdCella. The offer includes new shares and options, underpinned by key insiders and an underwriting agreement.

Anagenics Ltd has reported a significant earnings turnaround in 3Q25 following a strategic business restructure, alongside securing a multi-year royalty agreement worth $4.4 million with York Street Brands.

Caspin Resources has raised $2.1 million through a two-tranche equity placement to fund ongoing exploration at its promising Bygoo Tin Project, following encouraging high-grade drill results. The capital raise underscores strong investor confidence as further assay and metallurgical results are anticipated soon.